Status:

COMPLETED

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

Lead Sponsor:

University of Jordan

Conditions:

Pharmacist-Patient Relations

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

Detailed Description

About 103 patients with type 2 diabetes were randomized to control or intervention group, the control group received a standard care, while the intervention group received the collaborative care betwe...

Eligibility Criteria

Inclusion

  • type 2 diabetic patients who aged 18 years or more with a HbA1c reading 6.5 % or more at the time of diagnosis

Exclusion

  • pregnant patients
  • breastfeeding patients
  • patients with urgent or emergent cases
  • patients with cognitive impairment
  • if the patient is unable to provide informed written consent

Key Trial Info

Start Date :

October 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 24 2023

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT06029842

Start Date

October 17 2022

End Date

April 24 2023

Last Update

November 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Abu-Nsair medical center

Amman, Jordan

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan | DecenTrialz